PTEN and neoplasm: Mutations in TP53 and PTEN are rarely observed in UM, where loss-of-function mutations in BAP1 represent the most frequent tumor suppressor alteration.67,94,95 However, both TP53 and PTEN signaling pathways have been shown to be altered in UM pathogenesis.